GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (FRA:4DY) » Definitions » Gross Margin %

4d pharma (FRA:4DY) Gross Margin % : 0.00% (As of Dec. 2021)


View and export this data going back to 2020. Start your Free Trial

What is 4d pharma Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. 4d pharma's Gross Profit for the six months ended in Dec. 2021 was €0.34 Mil. 4d pharma's Revenue for the six months ended in Dec. 2021 was €0.34 Mil. Therefore, 4d pharma's Gross Margin % for the quarter that ended in Dec. 2021 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for 4d pharma's Gross Margin % or its related term are showing as below:


FRA:4DY's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.605
* Ranked among companies with meaningful Gross Margin % only.

4d pharma had a gross margin of N/A% for the quarter that ended in Dec. 2021 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for 4d pharma was 0.00% per year.


4d pharma Gross Margin % Historical Data

The historical data trend for 4d pharma's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Gross Margin % Chart

4d pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Gross Margin %
Get a 7-Day Free Trial - - - - -

4d pharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of 4d pharma's Gross Margin %

For the Biotechnology subindustry, 4d pharma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4d pharma's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4d pharma's Gross Margin % distribution charts can be found below:

* The bar in red indicates where 4d pharma's Gross Margin % falls into.



4d pharma Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

4d pharma's Gross Margin for the fiscal year that ended in Dec. 2021 is calculated as

Gross Margin % (A: Dec. 2021 )=Gross Profit (A: Dec. 2021 ) / Revenue (A: Dec. 2021 )
=0.6 / 0.614
=(Revenue - Cost of Goods Sold) / Revenue
=(0.614 - 0) / 0.614
=N/A %

4d pharma's Gross Margin for the quarter that ended in Dec. 2021 is calculated as


Gross Margin % (Q: Dec. 2021 )=Gross Profit (Q: Dec. 2021 ) / Revenue (Q: Dec. 2021 )
=0.3 / 0.341
=(Revenue - Cost of Goods Sold) / Revenue
=(0.341 - 0) / 0.341
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


4d pharma  (FRA:4DY) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

4d pharma had a gross margin of N/A% for the quarter that ended in Dec. 2021 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


4d pharma Gross Margin % Related Terms

Thank you for viewing the detailed overview of 4d pharma's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


4d pharma Business Description

Traded in Other Exchanges
N/A
Address
9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma Headlines

No Headlines